Chamseddine I, Kambara M, Bhatt P, Pilon-Thomas S, Rejniak K
bioRxiv. 2025; .
PMID: 39829889
PMC: 11741369.
DOI: 10.1101/2025.01.06.631283.
Magazine N, Zhang T, Bungwon A, McGee M, Wu Y, Veggiani G
Immunohorizons. 2024; 8(3):214-226.
PMID: 38427047
PMC: 10985062.
DOI: 10.4049/immunohorizons.2400003.
Magazine N, Zhang T, Bungwon A, McGee M, Wu Y, Veggiani G
bioRxiv. 2023; .
PMID: 37961687
PMC: 10634854.
DOI: 10.1101/2023.10.26.564184.
Shafaghi M, Bahadori Z, Madanchi H, Ranjbar M, Shabani A, Mousavi S
BMC Bioinformatics. 2023; 24(1):67.
PMID: 36829109
PMC: 9951839.
DOI: 10.1186/s12859-023-05175-6.
Chang T, Manabe Y, Ito K, Yamamoto R, Kabayama K, Ohshima S
RSC Adv. 2022; 12(29):18985-18993.
PMID: 35873332
PMC: 9241363.
DOI: 10.1039/d2ra03286d.
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.
Giurini E, Madonna M, Zloza A, Gupta K
Cancers (Basel). 2022; 14(12).
PMID: 35740589
PMC: 9221178.
DOI: 10.3390/cancers14122923.
Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection.
Kayesh M, Kohara M, Tsukiyama-Kohara K
Front Microbiol. 2021; 12:744233.
PMID: 34603272
PMC: 8483762.
DOI: 10.3389/fmicb.2021.744233.
Structure and compositional analysis of aluminum oxyhydroxide adsorbed pertussis vaccine.
Duprez J, Kalbfleisch K, Deshmukh S, Payne J, Haer M, Williams W
Comput Struct Biotechnol J. 2021; 19:439-447.
PMID: 33489011
PMC: 7804342.
DOI: 10.1016/j.csbj.2020.12.023.
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.
Bunch B, Kodumudi K, Scott E, Morse J, Weber A, Berglund A
Cancer Immunol Immunother. 2020; 69(12):2465-2476.
PMID: 32556443
PMC: 7680263.
DOI: 10.1007/s00262-020-02634-4.
Surface Immunogenic Protein of Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant.
Diaz-Dinamarca D, Manzo R, Soto D, Avendano-Valenzuela M, Bastias D, Soto P
Vaccines (Basel). 2020; 8(1).
PMID: 31963234
PMC: 7157747.
DOI: 10.3390/vaccines8010029.
Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases.
Santos S, Ramirez M, Miranda E, Reyes N, Martinez O, Acosta-Santiago M
J Immunol Res. 2019; 2019:3409371.
PMID: 31240233
PMC: 6556318.
DOI: 10.1155/2019/3409371.
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
Kumar S, Sunagar R, Gosselin E
Front Immunol. 2019; 10:1144.
PMID: 31191528
PMC: 6549121.
DOI: 10.3389/fimmu.2019.01144.
Spatial distribution of IL4 controls iNKT cell-DC crosstalk in tumors.
Wang L, Liu Z, Wang L, Wu Q, Li X, Xie D
Cell Mol Immunol. 2019; 17(5):496-506.
PMID: 31160756
PMC: 7192838.
DOI: 10.1038/s41423-019-0243-z.
Zymosan A enhances humoral immune responses to soluble protein in chickens.
Abou Elazab M, Inoue Y, Kamei H, Horiuchi H, Furusawa S
J Vet Med Sci. 2017; 79(8):1335-1341.
PMID: 28652560
PMC: 5573818.
DOI: 10.1292/jvms.16-0636.
Pet serine protease from enteroaggregative Escherichia coli stimulates the inflammatory response activating human macrophages.
Rocha-Ramirez L, Hernandez-Chinas U, Banos-Rojas D, Xicohtencatl-Cortes J, Chavez-Berrocal M, Rico-Rosillo G
BMC Microbiol. 2016; 16(1):158.
PMID: 27439312
PMC: 4955197.
DOI: 10.1186/s12866-016-0775-7.
Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
Kim K, Lee Y, Hwang H, Kwon Y, Jung Y, Lee Y
PLoS One. 2015; 10(10):e0139916.
PMID: 26468884
PMC: 4607166.
DOI: 10.1371/journal.pone.0139916.
Immunomodulator-based enhancement of anti smallpox immune responses.
Martinez O, Miranda E, Ramirez M, Santos S, Rivera C, Vazquez L
PLoS One. 2015; 10(4):e0123113.
PMID: 25875833
PMC: 4395221.
DOI: 10.1371/journal.pone.0123113.
Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant.
Wu M, Wang H, Shi J, Sun J, Duan Z, Li Y
Hum Vaccin Immunother. 2015; 10(12):3711-21.
PMID: 25668674
PMC: 4514065.
DOI: 10.4161/21645515.2014.980682.
Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.
Dalencon F
Hum Vaccin Immunother. 2013; 9(9):2013-4.
PMID: 23938771
PMC: 3906371.
DOI: 10.4161/hv.26074.
In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy.
Gahn B, Staudinger M, Woester K, Wellnitz D, Boettcher S, Gramatzki M
J Thorac Dis. 2013; 5(3):240-50.
PMID: 23825754
PMC: 3698248.
DOI: 10.3978/j.issn.2072-1439.2013.05.07.